Witrynaimgn Was Designed by Industry Professionals for Industry Professionals With a Vision of Making Productions Faster, Cheaper and Scalable ... Play. Previous. Next. Your Production Deserves the Power of Deep Technology. Check Us Out. Contact us. Name Email Address Message Send. Upload script Witryna10 kwi 2024 · From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $76.1 million. The company’s revenue is forecast to grow by 45.90% over what it did in 2024. A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Ardelyx Inc.
IMGN - ImmunoGen, Inc. Stock Price and Quote - FINVIZ.com
Witryna-0.68 Home IMGN • NASDAQ ImmunoGen, Inc. Follow Share $4.06 After Hours: $4.12 (1.48%) +0.060 Closed: Apr 6, 4:44:00 PM GMT-4 · USD · NASDAQ · Disclaimer … Witryna5 kwi 2024 · Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen ... cub foods pharmacy university
Immunogen, Inc. (IMGN) Stock Price Today, News, Quotes, FAQs …
Witryna11 kwi 2024 · About IMGN. ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant … Witryna10 kwi 2024 · Business. The trading price of ImmunoGen Inc. (NASDAQ:IMGN) closed higher on Thursday, April 06, closing at $4.06, 4.37% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $3.905 and $4.10. In examining the 52-week price action we see … WitrynaCompany profile page for ImmunoGen Inc including stock price, company news, press releases, executives, board members, and contact information cub foods pharmacy shorewood mn